Today, on 27th March 2025, Samvardhana Motherson International Limited SMIL Share Price has experienced a slight decline of 3% in its share prices since the last market close. This decline follows despite CSLA’s predictions of stock growth in the next three years and Goldman Sachs’ acquisition of 6.54 million in shares for an average rate of 137 per share.
CSLA, a notable global brokerage firm, said that SMIL’s share price could double in three years. CSLA has an “outperform” rating and predicted a share price target of Rs. 167. Despite the impact of the US tariffs on companies like SMIL, CSLA said that over the financial year 2025, it expects SMIL’s revenue to grow at a compound annual Growth Rate (CAGR) of 11%. CSLA expects SMIL’s 2027 revenue to be around $16 billion, with EBITDA margins at 9.5%.
SMIL’s Share Price in Today’s Market
Today, SMIL’s shares opened to the market at Rs. 130.50 and are currently down by 2.57% compared to the previous session’s close of Rs. 134.93.
At 10:25 a.m., SMIL’s share price was Rs. 132.04, nearly 2.1% lower than the previous close. According to the reports and estimates on Money Control, the current market capitalization shows 92,843 cores; the UC Limit is 148.42, and the LC Limit is 121.43.
Company Financials
SMIL reported a revenue of Rs. 27.23KCr for the quarter ending in December 2024, marking a 6.97% increase YoY. Its net income was Rs. 878.63Cr, marking a 62.12% YoY and a net profit margin of 3.23%, a 51.64% spike from the previous year’s quarter. SMIL’s Operating income was Rs. 1.57KCr, marking a 16.27% increase compared to the last year.
Recent News About SMIL
- On 21st March, SMIL announced an equity dividend of Rs. ₹0.5 per share. The ex-dividend date is set for 28th March.
SMIL Share Price Target
As per experts’ reports on Trendlyne, Samvardhana Motherson International Ltd. has an average target of 175. The consensus estimate represents an upside of 32.30% from the last price of 132.28.
Should You Buy, Sell, Or Hold?
Experts strongly recommend buying the shares. 21 out of 25 SMIL analysts recommend buying, while the rest are divided between selling and holding. Before investing in the company, consider its long-term performance and consult your analyst to make the perfect move.
